HOME >> MEDICINE >> NEWS
LSUHSC innovation in patient safety training to improve surgical outcomes

New OrleansOn Wednesday, August 17, 2005 at 11:00 a.m. in the Isidore Cohn Learning Center on the campus of Louisiana State University (LSU) Health Sciences Center in New Orleans, a surgical team comprising surgery residents, anesthesiologists, circulating nurses, nurse anesthesia students, and medical students, will be thrown into a scenario where their patient develops a potentially fatal cardiac arrhythmia during a gallbladder operation. Other crises may occur as well, depending upon how the surgical team performs. Through a peerless combination and adaptation of the most sophisticated medical simulation and virtual technology developed to date, faculty at LSU Health Sciences Center (LSUHSC) in New Orleans are now training future generations of medical professionals to anticipate and avoid medical errors. To our knowledge, there is not another set-up like it anywhere in the United States. While other universities are using simulators and still others are doing mock training exercises, there is not another program that has connected independent technologies to relate laparoscopic surgery to a "live patient" in an environment with the look, feel, and function of a real minimally invasive operating theater.

Through industry partnerships, LSUHSC faculty have equipped a minimally invasive operating room with new-era lights, monitors, and cameras, and a fully responsive human patient simulator that faculty program to physiologically respond just like a patient undergoing surgery performed with a virtual reality laparoscopic surgery simulator. A quad split screen monitor displaying the OR activity, vital signs, the surgical field, and the scenario allows not only the surgical team to check information, but those immediately outside the virtual OR as well those in a large adjacent conferencing facility can monitor and also learn from the case.

Satellite capability will permit broadcast to remote locations as well.

Taking off on the airline industry's con
'"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Science Center
5-Aug-2005


Page: 1 2 3

Related medicine news :

1. LSUHSC awarded designation resulting in improved patient safety and outcomes
2. LSUHSC public health documents unmet health needs of Katrina-displaced
3. How innovation drives our economy set for June 5 at UD
4. World-leading innovation in child-allergy detection
5. Rush University Simulation Laboratory honored for innovation
6. Binghamton University researchers ready nanotechnology innovations for market
7. Plastic surgery reflects on its past; Highlights innovations for the future of the specialty
8. Karolinska Institutet prize for innovations in medical pedagogics
9. OSA Frontiers in Optics annual meeting celebrates 90th anniversary of innovation in optics
10. Research team sweeps the board with intensive care innovations
11. Refinements and innovations enhance safety, effectiveness

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: